A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
Trial details
- Registry ID
- NCT07402876
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Trial Evaluating Patients With Primary Vitreoretinal LymphomaNCT07402876 | ALDX | Phase 3 | Recruiting | 2029-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |